Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension.
Messerli
Franz H
FH
Division of Cardiology, St Luke's-Roosevelt Hospital, Columbia University College of Physicians and Surgeons, 1000 10th Ave, Suite 3B-30, New York, NY 10019, USA. fmesserli@aol.com
Bangalore
Sripal
S
Julius
Stevo
S
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000139:chemically induced*; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D004232:Diuretics